Viewing Study NCT00378066


Ignite Creation Date: 2025-12-24 @ 4:36 PM
Ignite Modification Date: 2025-12-26 @ 6:54 PM
Study NCT ID: NCT00378066
Status: COMPLETED
Last Update Posted: 2013-01-23
First Post: 2006-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer
Sponsor: Asan Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module